PharmiWeb.com - Global Pharma News & Resources
06-Mar-2019

BioMarin to Participate in Cowen and Company 39th Annual Health Care Conference on March 12 in Boston

SAN RAFAEL, Calif., March 6, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaim√©, Chairman and Chief Executive Officer, will present at the Cowen and Company Health Care Conference on March 12 at 10:40am ET in Boston.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:




Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-cowen-and-company-39th-annual-health-care-conference-on-march-12-in-boston-300807329.html

SOURCE BioMarin Pharmaceutical Inc.

Editor Details

Last Updated: 06-Mar-2019